1-2 of 2
Gülden Özen
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Recombinant von Willebrand factor prophylaxis in patients with severe von Willebrand disease: phase 3 study results

Clinical Trials & Observations
Frank W. G. Leebeek, Flora Peyvandi, Miguel Escobar, Andreas Tiede, Giancarlo Castaman, Michael Wang, Tung Wynn, Jovanna Baptista, Yi Wang, Jingmei Zhang, Björn Mellgård, Gülden Özen
Journal: Blood
Blood (2022) 140 (2): 89–98.
https://doi.org/10.1182/blood.2021014810
Published: 2022
Includes: Supplemental data
Journal Articles

Exposure-Response Relationship between Von Willebrand Factor (VWF) Activity and Bleeding Events Following Prophylaxis with Recombinant VWF (rVWF, vonicog alfa) in Patients with Severe Von Willebrand Disease (VWD)

Yi Wang, Gülden Özen, Björn Mellgård, Jean Francois Marier, Olivier Barriere, Grygoriy Vasilinin, Indranil Bhattacharya
Journal: Blood
Blood (2021) 138 (Supplement 1): 2104.
https://doi.org/10.1182/blood-2021-146153
Published: 2021